China leads new healthcare alliance to expand its dominance across Asia-Pacific |
China is systematically building healthcare technology dominance across Asia-Pacific by positioning genomics companies as essential infrastructure partners for developing economies. The HGP2 Rare Disease Alliance was launched on May 10 in Kuala Lumpur, uniting 10 countries under a shared framework.
BGI Genomics, the Chinese company leading this initiative, is deploying high-throughput sequencing systems and AI-powered diagnostic platforms throughout Southeast Asia and South........